Bullish option flow detected in Crispr Therapeutics with 7,189 calls trading, 1.4x expected, and implied vol increasing over 4 points to 74.60%. Dec-23 67 calls and Dec-23 71 calls are the most active options, with total volume in those strikes near 3,000 contracts. The Put/Call Ratio is 0.16. Earnings are expected on February 20th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CRSP:
- Biotech Alert: Searches spiking for these stocks today
- Crispr Therapeutics call volume above normal and directionally bullish
- Crispr Therapeutics (NASDAQ:CRSP) Notches Up on World-First Therapy
- Vertex Pharmaceuticals, Crispr Therapeutics get MHRA authorization for Casgevy
- Crispr Therapeutics price target lowered to $50 from $55 at RBC Capital
